Protein kinase C isozymes as potential therapeutic targets in immune disorders

Expert Opinion on Therapeutic Targets
Matthew R LeeSeng-Lai Tan

Abstract

Members of the protein kinase C (PKC) family are key signalling mediators in immune responses, and pharmacological inhibition of PKCs may be useful for treating immune-mediated diseases. To review and discuss the insights gained so far into various PKC isozymes and the therapeutic potential and challenges of developing PKC inhibitors for immune disorder therapy. A literature review of the role of PKCs in immune cell signalling and recent studies describing immune functions associated with PKC isozyme deficiency in relevant mouse disease models, followed by specific case studies of current and potential therapeutic strategies targeting PKCs. There is vast amount of data supporting PKC isozymes as attractive drug targets for certain immune disorders. Although the development of specific PKC isozyme inhibitors has been challenging, some progress has been made. It remains to be seen if broad-scale or isozyme-selective inhibition of PKC will have clinical efficacy.

References

Sep 1, 1992·Agents and Actions·M J MulqueenA D Sedgwick
Aug 9, 1996·Science·M LeitgesA Tarakhovsky
Apr 7, 1998·Clinical and Experimental Immunology·L SvenssonL Jansson
Feb 23, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S Jaken, P J Parker
Feb 13, 2001·European Journal of Immunology·B BauerG Baier
Mar 27, 2001·British Journal of Cancer·F H BlackhallUNKNOWN Cancer Research Campaign Phase I/II Committee
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E A SausvilleA M Senderowicz
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·T M HerndonR L Wange
May 3, 2001·Melanoma Research·A Y BedikianT Smith
Nov 7, 2001·The Journal of Experimental Medicine·A CastrilloL Boscá
Dec 6, 2001·Current Oncology Reports·Helen C Swannie, Stanley B Kaye
Apr 27, 2002·Nature·Ingrid MecklenbräukerAlexander Tarakhovsky
May 25, 2002·Molecular and Cellular Biology·Michael LeitgesMichael Huber
Jul 30, 2002·The EMBO Journal·Pilar MartinJorge Moscat
Aug 3, 2002·Nature Immunology·Donghai WangXin Lin
Feb 4, 2003·Nature Reviews. Drug Discovery·Chris J VlahosAngela Clerk
Jun 5, 2003·The Journal of Experimental Medicine·Christa PfeifhoferGottfried Baier
Jul 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yuko KawakamiToshiaki Kawakami
Aug 6, 2003·American Journal of Physiology. Cell Physiology·Suzana D SavkovicGail Hecht
Dec 17, 2003·Journal of Cell Science·Peter J Parker, Judith Murray-Rust
Mar 17, 2004·The Journal of Experimental Medicine·Nancy N Berg-BrownPamela S Ohashi
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Marc Schmidt-SupprianKlaus Rajewsky
Jul 21, 2004·The Journal of Experimental Medicine·Benjamin J MarslandManfred Kopf

❮ Previous
Next ❯

Citations

Dec 1, 2012·Nature Reviews. Drug Discovery·Daria Mochly-RosenKevin V Grimes
Nov 3, 2012·Interdisciplinary Toxicology·Katarína DrábikováViera Jančinová
Nov 15, 2011·Bioorganic & Medicinal Chemistry Letters·Maurice J van EisNicolas Soldermann
Jan 12, 2011·Biochemical and Biophysical Research Communications·Yuri SaitoYuzuru Kanakura
Nov 30, 2013·Basic & Clinical Pharmacology & Toxicology·Eeva Moilanen
Oct 11, 2013·Basic & Clinical Pharmacology & Toxicology·Tiina LeppänenEeva Moilanen
Sep 1, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Bálint BotzZsuzsanna Helyes
Aug 1, 2009·Journal of the American Chemical Society·Tianzhi ZhangEric V Anslyn
Jan 18, 2018·The Journal of Comparative Neurology·Marion F HaugStephan C F Neuhauss
Jan 24, 2014·Beilstein Journal of Organic Chemistry·Tapan SahaShital K Chattopadhyay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.